ATE334980T1 - Verfahren zur herstellung von 2-methyl piperazine derivaten. - Google Patents

Verfahren zur herstellung von 2-methyl piperazine derivaten.

Info

Publication number
ATE334980T1
ATE334980T1 AT03736405T AT03736405T ATE334980T1 AT E334980 T1 ATE334980 T1 AT E334980T1 AT 03736405 T AT03736405 T AT 03736405T AT 03736405 T AT03736405 T AT 03736405T AT E334980 T1 ATE334980 T1 AT E334980T1
Authority
AT
Austria
Prior art keywords
producing
methyl piperazine
piperazine derivatives
relates
present
Prior art date
Application number
AT03736405T
Other languages
English (en)
Inventor
Magnus Cernerud
Helena Lundstroem
Claes Loefstroem
Margit Pelcman
Tom Di Fleck
Alexander Paptchikhine
Emma Andersson
Alf Nygren
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0201881A external-priority patent/SE0201881D0/xx
Priority claimed from SE0202041A external-priority patent/SE0202041D0/xx
Priority claimed from SE0202516A external-priority patent/SE0202516D0/xx
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Application granted granted Critical
Publication of ATE334980T1 publication Critical patent/ATE334980T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Luminescent Compositions (AREA)
  • Pyridine Compounds (AREA)
AT03736405T 2002-06-19 2003-06-18 Verfahren zur herstellung von 2-methyl piperazine derivaten. ATE334980T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
SE0201881A SE0201881D0 (sv) 2002-06-19 2002-06-19 Novel compounds, their use, and preparation
US39065602P 2002-06-21 2002-06-21
SE0202041A SE0202041D0 (sv) 2002-06-28 2002-06-28 Novel process
US40611902P 2002-08-26 2002-08-26
SE0202516A SE0202516D0 (sv) 2002-08-26 2002-08-26 Novel compounds, their use, and preparation
US41670102P 2002-10-07 2002-10-07

Publications (1)

Publication Number Publication Date
ATE334980T1 true ATE334980T1 (de) 2006-08-15

Family

ID=30004077

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05023471T ATE398119T1 (de) 2002-06-19 2003-06-18 Piperazinylpyrazine als modulatoren des serotonin 5-ht2c rezeptors
AT03736405T ATE334980T1 (de) 2002-06-19 2003-06-18 Verfahren zur herstellung von 2-methyl piperazine derivaten.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05023471T ATE398119T1 (de) 2002-06-19 2003-06-18 Piperazinylpyrazine als modulatoren des serotonin 5-ht2c rezeptors

Country Status (16)

Country Link
EP (2) EP1529043B1 (de)
JP (4) JP4592417B2 (de)
CN (1) CN100334082C (de)
AT (2) ATE398119T1 (de)
AU (1) AU2003237746B8 (de)
CA (1) CA2485532C (de)
CY (1) CY1106225T1 (de)
DE (2) DE60307286T2 (de)
DK (2) DK1529043T3 (de)
ES (2) ES2270051T3 (de)
HK (1) HK1080079B (de)
NO (1) NO20050279D0 (de)
NZ (1) NZ536663A (de)
PT (2) PT1645558E (de)
SI (2) SI1645558T1 (de)
WO (1) WO2004000829A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5173190B2 (ja) 2004-08-25 2013-03-27 武田薬品工業株式会社 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
EP2727585A1 (de) 2006-05-16 2014-05-07 Takeda Pharmaceutical Company Limited In-vivo Screening-Methode
AU2008312948C1 (en) 2007-10-16 2012-08-09 Daiichi Sankyo Company, Limited Pyrimidyl indoline compound
EP2789338A3 (de) 2007-11-15 2015-01-14 Takeda Pharmaceutical Company Limited Kondensiertes Pyridinderivat und seine Verwendung
EA021079B1 (ru) 2009-06-15 2015-03-31 Такеда Фармасьютикал Компани Лимитед Производные пиразинооксазепина
EP2510949A4 (de) 2009-12-11 2013-11-13 Astellas Pharma Inc Therapeutikum für fibromyalgie
GB201304811D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Novel treatment for hypertension
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06306075A (ja) * 1993-04-23 1994-11-01 Sanwa Kagaku Kenkyusho Co Ltd エトキシベンズアミド誘導体
WO2000076984A2 (en) * 1999-05-21 2000-12-21 Biovitrum Ab Novel compounds, their use and preparation
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
NZ525699A (en) * 2000-11-20 2005-03-24 Biovitrum Ab Piperazinylpyrazines compounds as antagonists of serotonin 5-HT2 receptor

Also Published As

Publication number Publication date
JP2013116906A (ja) 2013-06-13
AU2003237746A1 (en) 2004-01-06
DK1529043T3 (da) 2006-12-04
HK1080079A1 (zh) 2006-04-21
PT1645558E (pt) 2008-07-30
JP2010120949A (ja) 2010-06-03
JP2005537316A (ja) 2005-12-08
ATE398119T1 (de) 2008-07-15
EP1645558A1 (de) 2006-04-12
NO20050279D0 (no) 2005-01-18
CN100334082C (zh) 2007-08-29
SI1645558T1 (sl) 2008-10-31
CA2485532C (en) 2012-03-06
DE60321606D1 (de) 2008-07-24
ES2307102T3 (es) 2008-11-16
EP1529043B1 (de) 2006-08-02
HK1080079B (zh) 2008-03-14
WO2004000829A1 (en) 2003-12-31
AU2003237746B8 (en) 2010-01-28
CA2485532A1 (en) 2003-12-31
JP4592417B2 (ja) 2010-12-01
EP1645558B1 (de) 2008-06-11
SI1529043T1 (sl) 2006-12-31
PT1529043E (pt) 2006-12-29
AU2003237746B2 (en) 2009-12-17
CN1662523A (zh) 2005-08-31
DE60307286T2 (de) 2007-10-25
DE60307286D1 (de) 2006-09-14
ES2270051T3 (es) 2007-04-01
CY1106225T1 (el) 2011-06-08
EP1529043A1 (de) 2005-05-11
JP2013227336A (ja) 2013-11-07
DK1645558T3 (da) 2008-10-06
NZ536663A (en) 2007-05-31
JP5378241B2 (ja) 2013-12-25

Similar Documents

Publication Publication Date Title
BR0311494A (pt) Novos indóis substituìdos
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
SE0303180D0 (sv) Novel compounds
DK1628685T3 (da) Antivirale phosphonatanaloge
SE0302232D0 (sv) Novel Compounds
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
IS6459A (is) Arýl sambrædd azapólýsýklísk efnasambönd
CY1112406T1 (el) Διενυδρη υδροχλωρικη (s)-(-)-1-(4-φθοροϊσοκινολιν-5-υλ)σουλφονυλ-2-μεθυλ-1,4-ομοπιπεραζινη
ATE432930T1 (de) Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen
ATE334980T1 (de) Verfahren zur herstellung von 2-methyl piperazine derivaten.
ATE354583T1 (de) Verfahren zur herstellung c-7 substituierter 5- androstene
ATE431735T1 (de) Fusionierte cycloalkyl amid- und carbonsäure- derivate und deren therapeutische verwendung zur behandlung von u.a. epilepsie
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
ATE424195T1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
DK1745010T3 (da) Substituerede cyklohexyl-1,4-diaminderivater
DE60335980D1 (de) Verfahren zur herstellung von synthetischen derivaten von dibenzylbutyrolacton-lignanen mit antichagas eigenschaften
MA27745A1 (fr) Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci.
ATE423775T1 (de) Verfahren zur herstellung von lactonen
EA200401432A1 (ru) Сложноэфирные производные декагидроизохинолин-3-карбоновой кислоты в качестве анальгетиков
ATE369849T1 (de) Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen
DE60310975D1 (de) Verwendung von epothilone zur behandlung hyperparathyreoidismus
SE0201881D0 (sv) Novel compounds, their use, and preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1529043

Country of ref document: EP